Peripheral Vascular Disease

Alternative Medicine The following information is specific for alternative and complementary medicine. For additional evidence-based information on diseases, conditions, symptoms, diagnosis, treatment and wellness issues, continue searching the Healthwise Knowledgebase.

Also indexed as:

Aneurysm, Buerger's Disease, Chronic Thromboangiitis, Occlusive Arterial Disease, Venous Thrombosis

Overview

What you need to know

Keep blood flowing freely through your legs and other parts of your body. According to research or other evidence, the following self-care steps may help you avert artery blockage:

• Support your circulation
• Ask your healthcare provider for advice on restoring or maintaining good circulation by exercising, avoiding prolonged standing or sitting, and using compression stockings

• Discover inositol hexaniacinate
• Take 1,200 mg a day of this nutritional supplement to help prevent and treat skin ulcers caused by peripheral vascular disease

• Say good-bye to smoking
• Avoid the damaging effects of nicotine on blood flow by kicking the habit

These recommendations are not comprehensive and are not intended to replace the advice of your doctor or pharmacist. Continue reading the full peripheral vascular disease article for more in-depth, fully-referenced information on medicines, vitamins, herbs, and dietary and lifestyle changes that may be helpful.

About peripheral vascular disease

Peripheral vascular disease (PVD) refers to a variety of conditions that primarily affect the arteries of the body, with the exception of the coronary arteries that supply blood to the heart. (Those are covered in the article on cardiovascular disease.) The most common areas for PVD are the arteries of the legs and upper arms, the carotid (neck) arteries, the abdominal aorta and its branches, and the renal (kidney) arteries.

The cause of most types of PVD is hardening of the arteries (atherosclerosis), which itself has many causes. Conditions affecting the veins, such as chronic venous insufficiency, varicose veins, and hemorrhoids, are not usually included in PVD.

PVD of the carotid arteries is a major cause of stroke. Intermittent claudication refers to pain in the lower legs after walking short distances and is caused by PVD of the leg arteries. One cause of erectile dysfunction may be PVD of the penis. Raynaud's disease is a painful condition caused by spasms of arteries after exposure to cold. Thromboangiitis obliterans (TAO), also known as Buerger's disease, is an uncommon PVD that occurs in both arteries and veins. This condition causes tender areas of inflammation in the arms or legs, followed by cold hands or feet.

Aneurysm is a ballooning of an artery due to weakening of the blood vessel walls. Aneurysms may be an inherited disorder or may be due to atherosclerosis.^{1, 2} The most common aneurysm is abdominal aortic aneurysm (AAA), which occurs in the large artery that carries blood from the heart to the lower body. AAA is much more common in men, and risk increases with age. Large AAAs are usually surgically repaired because they can undergo life-threatening ruptures.

Check list

Product ratings for peripheral vascular disease

Rating	Nutritional Supplements	Herbs
	Inositol hexaniacinate
	Copper (for abdominal aortic aneurysm) Folic acid (for thromboangiitis obliterans)
Reliable and relatively consistent scientific data showing a substantial health benefit. Contradictory, insufficient, or preliminary studies suggesting a health benefit or minimal health benefit. An herb is primarily supported by traditional use, or the herb or supplement has little scientific support and/or minimal health benefit.

Symptoms

What are the symptoms?

People with peripheral vascular disease may have symptoms of pain, aching, cramping, or fatigue of the muscles in the affected leg that are relieved by rest and worsened by elevation. Other people with peripheral vascular disease may have swollen feet and ankles accompanied by a dull ache made worse with prolonged standing and relieved by elevation. People with chronic peripheral vascular disease may have darkened areas of skin, leg ulcers, and varicose veins.

Lifestyle

Lifestyle changes that may be helpful

People with TAO are usually heavy smokers, and this is considered a major cause of the disease.³ It is important for people with TAO to quit smoking.

Supplements

Vitamins that may be helpful

As with other vascular diseases, people with TAO are more likely to have high levels of homocysteine and low levels of folic acid.⁴ However, no research has tested folic acid as prevention or treatment for this disease.

One controlled study compared a type of niacin (vitamin B3) known as inositol hexaniacinate to the drug pyridinolcarbamate for the treatment of skin ulcers caused by PVD.⁵ A placebo was not included in this trial, and both 1.2 grams daily of inositol hexaniacinate and 1.5 grams daily of the drug produced beneficial results in about half of the patients.

As in many vascular diseases, people with AAA often have abnormal cholesterol and triglyceride levels,⁶ and their blood vessel walls contain evidence of free radical damage.^{7, 8} However, it is not known whether lowering blood fats or taking free radical-destroying antioxidants will reduce the risk of AAA. The arterial walls of AAA are depleted of large molecules related to cartilage, including chondroitin sulfate,^{9, 10} but no research has investigated whether supplements of chondroitin sulfate might help prevent problems with AAA. Copper is required for normal artery structure.¹¹ Animal studies have shown that copper deficiency leads to weak aortic walls¹² and rupture of the aorta.¹³ Combating deficiency with copper supplements prevented rupture in an animal study.¹⁴ Copper deficiency in humans with AAA has been suggested in some studies,^{15, 16} but not in others.^{17, 18, 19} No studies have been done using copper supplements to prevent or manage aneurysms.

Are there any side effects or interactions?

Refer to the individual supplement for information about any side effects or interactions.

Other Alternatives

Holistic approaches that may be helpful

Intravenous chelation therapy has been reported to be an effective treatment for PVD.^{20, 21} A partially controlled study reported improvements after ten chelation treatments.²² However, two double-blind studies found no difference between chelation therapy and a placebo in patients with intermittent claudication.^{23, 24}

Preliminary reports suggest acupuncture may reduce pain and improve blood flow in TAO,^{25, 26} but controlled studies are needed to better evaluate these claims.

References

1. Anderson LA. An update on the cause of abdominal aortic aneurysms. J Vasc Nurs 1994;12:95-100 [review].
2. MacSweeney ST, Powell JT, Greenhalgh RM. Pathogenesis of abdominal aortic aneurysm. Br J Surg 1994;81:935-41 [review].
3. Szuba A, Cooke JP. Thromboangiitis obliterans. An update on Buerger's disease. West J Med 1998;168:255-60 [review].
4. Stammler F, Diehm C, Hsu E, et al. The prevalence of hyperhomocysteinemia in thromboangiitis obliterans. Does homocysteine play a role pathogenetically? Dtsch Med Wochenschr 1996;121:1417-23 [in German].
5. Mishima Y, Kamiya K, Sakaguchi S, et al. A multiclinic double-blind trial of pyridinolcarbamate and inositol niacinate in ischemic ulcer due to chronic arterial occlusion. Angiology 1977;28:84-94.
6. Watt HC, Law MR, Wald NJ, et al. Serum triglyceride: a possible risk factor for ruptured abdominal aortic aneurysm. Int J Epidemiol 1998;27:949-52.
7. Killion SL, Hunter GC, Eskelson CD, et al. Vitamin E levels in human atherosclerotic plaque: the influence of risk factors. Atherosclerosis 1996;126:289-97.
8. Dubick MA, Hunter GC, Casey SM, Keen CL. Aortic ascorbic acid, trace elements, and superoxide dismutase activity in human aneurysmal and occlusive disease. Proc Soc Exp Biol Med 1987;184:138-43.
9. Theocharis AD, Tsolakis I, Tsegenidis T, Karamanos NK. Human abdominal aortic aneurysm is closely associated with compositional and specific structural modifications at the glycosaminoglycan level. Atherosclerosis 1999;145:359-68.
10. Sobolewski K, Wolanska M, Bankowski E, et al. Collagen, elastin and glycosaminoglycans in aortic aneurysms. Acta Biochim Pol 1995;42:301-7.
11. Hill CH. A role of copper in elastin formation. Nutr Rev 1969;27:99-100 [review].
12. Greene FL, Lamb LS, Barwick M, Pappas NJ. Effect of dietary copper on colonic tumor production and aortic integrity in the rat. J Surg Res 1987;42:503-12.
13. Vanhooser SL, Stair E, Edwards WC, et al. Aortic rupture in ostrich associated with copper deficiency. Vet Hum Toxicol 1994;36:226-7.
14. Guenthner E, Carlson CW, Emerick RJ. Copper salts for growth stimulation and alleviation of aortic rupture losses in turkeys. Poult Sci 1978;57:1313-24.
15. Tilson MD. Decreased hepatic copper levels. A possible chemical marker for the pathogenesis of aortic aneurysms in man. Arch Surg 1982;117:1212-3.
16. Tilson MD, Davis G. Deficiencies of copper and a compound with ion-exchange characteristics of pyridinoline in skin from patients with abdominal aortic aneurysms. Surgery 1983;94:134-41.
17. Senapati A, Carlsson LK, Fletcher CD, et al. Is tissue copper deficiency associated with aortic aneurysms? Br J Surg 1985;72:352-3.
18. Dubick MA, Hunter GC, Casey SM, Keen CL. Aortic ascorbic acid, trace elements, and superoxide dismutase activity in human aneurysmal and occlusive disease. Proc Soc Exp Biol Med 1987;184:138-43.
19. Jaakkola P, Hippelainen M, Kantola M. Copper and zinc concentrations of abdominal aorta and liver in patients with infrarenal abdominal aortic aneurysm or aortoiliacal occlusive disease. Ann Chir Gynaecol 1994;83:304-8.
20. Olszewer E, Carter JP. EDTA chelation therapy in chronic degenerative disease. Med Hypotheses 1988;27:41-9.
21. Chappell LT, Janson M. EDTA chelation therapy in the treatment of vascular disease. J Cardiovasc Nurs 1996;10:78-86.
22. Olszewer E, Sabbag FC, Carter JP. A pilot double-blind study of sodium-magnesium EDTA in peripheral vascular disease. J Natl Med Assoc 1990;82:173-7.
23. Guldager B, Jelnes R, Jorgensen SJ, et al. EDTA treatment of intermittent claudication-a double-blind, placebo-controlled study. J Intern Med 1992;231:261-7.
24. Van Rij AM, Solomon C, Packer SGK, Hopkins WG. Chelation therapy for intermittent claudication. A double-blind, randomized, controlled trial. Circulation 1994;90:1194-9.
25. Zheng P. Traditional Chinese medicine anesthesia in severe thromboangiitis obliterans. Report of 30 cases. Chin Med J (Engl) 1988;101(3):221-4.
26. Yang BH, Zhang SG. Study of thromboangiitis obliterans treated with "vascular no. 3" using Doppler ultrasound. Chung Hsi I Chieh Ho Tsa Chih 1989;9:596-8, 581 [in Chinese].

---

Last Review: 09-01-2007

Copyright © 2007 Healthnotes, Inc.  All rights reserved. www.healthnotes.com

Learn more about Healthnotes, the company.

Learn more about the authors of Healthnotes.

The information presented in Healthnotes is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires September 2008.

	Go to top of page
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.